• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辐射诱导的细胞外基质重塑驱动肌肉浸润性膀胱癌的预后并预测放疗反应。

Radiation-induced extracellular matrix remodelling drives prognosis and predicts radiotherapy response in muscle-invasive bladder cancer.

作者信息

Guerrero Quiles Conrado, Fahy Siobhan, Bartak Matej, Gonzalez Abalos Julia, Powell Emilia, Lodhi T, Reed Rachel, Reeves Kim, Baker Alex, James Nicholas D, Hall Emma, Huddart Robert A, Porta Nuria, Hoskin Peter, West Catharine, Biolatti Luisa V, Choudhury Ananya

机构信息

Division of Cancer Sciences, The University of Manchester, The Christie Hospital National Health Service (NHS) Foundation Trust, Manchester, United Kingdom.

Institute Curie, Immunity and Cancer Unit (U932), Paris, France.

出版信息

Front Oncol. 2025 Jul 28;15:1616943. doi: 10.3389/fonc.2025.1616943. eCollection 2025.

DOI:10.3389/fonc.2025.1616943
PMID:40792276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12336036/
Abstract

Muscle-invasive bladder cancer (MIBC) is a prevalent disease that can be treated with radiotherapy, but has a poor prognosis. Radiation-induced extracellular matrix (ECM) remodelling and fibrosis can induce tumour resistance and recurrence, but have not been studied in MIBC. Here, we aimed to characterise the impact of radiation on the ECM composition of MIBC. Three MIBC cell lines (T24, UMUC3, J82) were treated with fractionated radiation. We used proteomics to analyse the ECM composition produced by surviving cancer cells and immunofluorescence to investigate changes in the morphology and number of ECM fibres. We evaluated the RNA expression of identified ECM proteins (FN1, COL5A1, COL1A1, TNF6AIP6, FLG) in one cystectomy (TCGA-BLCA, n=397) and two radiotherapy (BC2001, n=313; BCON, n=151) cohorts. There were 613 proteins affected by radiation (p<0.05, fold change >2 or <-2), 68 of which were ECM-associated proteins. There was a general increase in proteases and protease regulators but heterogeneity across cell lines. Enrichment analysis showed ECM organisation was the primary pathway affected. Immunofluorescence confirmed radiation affected ECM structure, generally, reducing the number, length and width of fibres. Five ECM genes of interest were identified (, , , , ), constituting an ECM signature. High , mRNA levels and ECM signature scores were independent poor prognostic markers, while mRNA expression independently predicted radiotherapy benefit in a meta-analysis (n=861). We found high expression levels predicted hypoxia-modifying treatment benefit. Prognostic significance of , and the ECM signature was dependent on patients harbouring -mutations. Radiation alters the composition and structure of the ECM produced by MIBC. As a proof-of-concept, we showed that radiation-affected ECM genes are independent prognostic and predictive markers of radiotherapy benefit in MIBC. Future studies should validate these radiation-induced ECM changes in clinical samples, and explore the role of in radioresistance.

摘要

肌肉浸润性膀胱癌(MIBC)是一种常见疾病,可采用放射治疗,但预后较差。辐射诱导的细胞外基质(ECM)重塑和纤维化可诱导肿瘤耐药性和复发,但在MIBC中尚未得到研究。在此,我们旨在描述辐射对MIBC细胞外基质组成的影响。对三种MIBC细胞系(T24、UMUC3、J82)进行分次辐射处理。我们使用蛋白质组学分析存活癌细胞产生的细胞外基质组成,并通过免疫荧光研究细胞外基质纤维的形态和数量变化。我们评估了一个膀胱切除术队列(TCGA - BLCA,n = 397)和两个放射治疗队列(BC2001,n = 313;BCON,n = 151)中已鉴定的细胞外基质蛋白(FN1、COL5A1、COL1A1、TNF6AIP6、FLG)的RNA表达。有613种蛋白质受辐射影响(p < 0.05,倍数变化>2或< -2),其中68种是与细胞外基质相关的蛋白质。蛋白酶和蛋白酶调节剂总体上有所增加,但各细胞系存在异质性。富集分析表明细胞外基质组织是受影响的主要途径。免疫荧光证实辐射影响细胞外基质结构,一般会减少纤维的数量、长度和宽度。鉴定出五个感兴趣的细胞外基质基因(此处原文缺失具体基因名称),构成一个细胞外基质特征。高(此处原文缺失具体基因名称)、(此处原文缺失具体基因名称)mRNA水平和细胞外基质特征评分是独立的不良预后标志物,而(此处原文缺失具体基因名称)mRNA表达在一项荟萃分析(n = 861)中独立预测放射治疗获益。我们发现高(此处原文缺失具体基因名称)表达水平预测低氧修饰治疗获益。(此处原文缺失具体基因名称)、(此处原文缺失具体基因名称)和细胞外基质特征的预后意义取决于携带(此处原文缺失具体基因突变名称)突变的患者。辐射改变了MIBC产生的细胞外基质的组成和结构。作为概念验证,我们表明受辐射影响的细胞外基质基因是MIBC放射治疗获益的独立预后和预测标志物。未来的研究应在临床样本中验证这些辐射诱导的细胞外基质变化,并探索(此处原文缺失具体基因名称)在放射抗性中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3b6/12336036/2b454842c43a/fonc-15-1616943-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3b6/12336036/eec4d9f5ec24/fonc-15-1616943-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3b6/12336036/c308eb181b29/fonc-15-1616943-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3b6/12336036/b359dc9d3005/fonc-15-1616943-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3b6/12336036/b1675d21591b/fonc-15-1616943-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3b6/12336036/b455530582e7/fonc-15-1616943-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3b6/12336036/5ad43c6d86da/fonc-15-1616943-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3b6/12336036/2b454842c43a/fonc-15-1616943-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3b6/12336036/eec4d9f5ec24/fonc-15-1616943-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3b6/12336036/c308eb181b29/fonc-15-1616943-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3b6/12336036/b359dc9d3005/fonc-15-1616943-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3b6/12336036/b1675d21591b/fonc-15-1616943-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3b6/12336036/b455530582e7/fonc-15-1616943-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3b6/12336036/5ad43c6d86da/fonc-15-1616943-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3b6/12336036/2b454842c43a/fonc-15-1616943-g007.jpg

相似文献

1
Radiation-induced extracellular matrix remodelling drives prognosis and predicts radiotherapy response in muscle-invasive bladder cancer.辐射诱导的细胞外基质重塑驱动肌肉浸润性膀胱癌的预后并预测放疗反应。
Front Oncol. 2025 Jul 28;15:1616943. doi: 10.3389/fonc.2025.1616943. eCollection 2025.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
4
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.欧洲癌症研究与治疗组织(EORTC)癌症贫血患者促红细胞生成蛋白使用指南:2006年更新版
Eur J Cancer. 2007 Jan;43(2):258-70. doi: 10.1016/j.ejca.2006.10.014. Epub 2006 Dec 19.
5
Effectiveness of different treatment modalities for the management of adult-onset granulosa cell tumours of the ovary (primary and recurrent).不同治疗方式对成人卵巢颗粒细胞瘤(原发性和复发性)治疗的有效性
Cochrane Database Syst Rev. 2014 Apr 21;2014(4):CD006912. doi: 10.1002/14651858.CD006912.pub2.
6
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.未治疗的霍奇金淋巴瘤患者化疗和放疗在第二原发性恶性肿瘤、总生存期和无进展生存期方面的优化:个体参与者数据分析
Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD008814. doi: 10.1002/14651858.CD008814.pub2.
8
A systematic overview of radiation therapy effects in urinary bladder cancer.膀胱癌放射治疗效果的系统综述。
Acta Oncol. 2003;42(5-6):567-81. doi: 10.1080/02841860310014408.
9
Multi-omics analysis unveils the predictive value of IGF2BP3/SPHK1 signaling in cancer stem cells for prognosis and immunotherapeutic response in muscle-invasive bladder cancer.多组学分析揭示了 IGF2BP3/SPHK1 信号在肌层浸润性膀胱癌肿瘤干细胞中对预后和免疫治疗反应的预测价值。
J Transl Med. 2024 Oct 4;22(1):900. doi: 10.1186/s12967-024-05685-8.
10
Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.乳腺密度、内分泌治疗与乳腺癌风险:预后和预测生物标志物综述。
Cochrane Database Syst Rev. 2021 Oct 26;10(10):CD013091. doi: 10.1002/14651858.CD013091.pub2.

本文引用的文献

1
Role and potential therapeutic strategies of matrix mechanics for optimizing tumor radiotherapy.基质力学在优化肿瘤放疗中的作用及潜在治疗策略
Mechanobiol Med. 2023 Dec 19;2(1):100037. doi: 10.1016/j.mbm.2023.100037. eCollection 2024 Mar.
2
High Mechanical Conditioning by Tumor Extracellular Matrix Stiffness Is a Predictive Biomarker for Antifibrotic Therapy in HER2-Negative Breast Cancer.肿瘤细胞外基质硬度的高机械调节是 HER2 阴性乳腺癌抗纤维化治疗的预测性生物标志物。
Clin Cancer Res. 2024 Nov 15;30(22):5094-5104. doi: 10.1158/1078-0432.CCR-24-1518.
3
Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours.
肿瘤对缺氧的反应:了解缺氧肿瘤微环境以改善实体瘤的治疗效果
Front Oncol. 2024 Jan 30;14:1331355. doi: 10.3389/fonc.2024.1331355. eCollection 2024.
4
Cell jamming in a collagen-based interface assay is tuned by collagen density and proteolysis.细胞在基于胶原蛋白的界面分析中被阻断是通过胶原蛋白密度和蛋白水解来调节的。
J Cell Sci. 2023 Dec 1;136(23). doi: 10.1242/jcs.260207. Epub 2023 Dec 15.
5
Tissue fibrosis induced by radiotherapy: current understanding of the molecular mechanisms, diagnosis and therapeutic advances.放疗诱导的组织纤维化:分子机制、诊断及治疗进展的最新认识。
J Transl Med. 2023 Oct 9;21(1):708. doi: 10.1186/s12967-023-04554-0.
6
Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal.在 cBioPortal 中分析和可视化 AACR 项目 GENIE 生物制药协作的纵向基因组和临床数据。
Cancer Res. 2023 Dec 1;83(23):3861-3867. doi: 10.1158/0008-5472.CAN-23-0816.
7
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.PI3K/AKT/mTOR 信号转导通路与癌症的靶向治疗。
Mol Cancer. 2023 Aug 18;22(1):138. doi: 10.1186/s12943-023-01827-6.
8
The role of CXCL family members in different diseases.CXCL家族成员在不同疾病中的作用。
Cell Death Discov. 2023 Jul 1;9(1):212. doi: 10.1038/s41420-023-01524-9.
9
Molecular mechanisms of tumor resistance to radiotherapy.肿瘤放疗抵抗的分子机制。
Mol Cancer. 2023 Jun 15;22(1):96. doi: 10.1186/s12943-023-01801-2.
10
Elevated Baseline Neutrophil Count Correlates with Worse Outcomes in Patients with Muscle-Invasive Bladder Cancer Treated with Chemoradiation.基线中性粒细胞计数升高与接受放化疗的肌层浸润性膀胱癌患者的较差预后相关。
Cancers (Basel). 2023 Mar 21;15(6):1886. doi: 10.3390/cancers15061886.